Calidi Biotherapeutics, Inc.

CLDI ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
NT 10-Q Aug 15, 2023 NT 10-Q
SEC STAFF LETTER Aug 8, 2023
425 Aug 7, 2023 425
EFFECT Aug 4, 2023
424B3 Aug 4, 2023 424B3
CORRESP Aug 3, 2023
S-4/A Aug 2, 2023 S-4/A
S-4/A Aug 1, 2023 S-4/A
SEC STAFF LETTER Jul 26, 2023
S-4/A Jul 25, 2023 S-4/A
CORRESP Jul 24, 2023
425 Jul 18, 2023 425
UPLOAD Jul 14, 2023
S-4/A Jul 3, 2023 S-4/A
CORRESP Jun 30, 2023
SC 13D/A Jun 28, 2023 AMENDMENT NO. 2 TO SCHEDULE 13D
425 Jun 23, 2023 425
8-K Jun 23, 2023 8-K
8-K Jun 16, 2023 8-K
UPLOAD May 18, 2023
10-Q May 15, 2023 10-Q
S-4/A May 9, 2023 S-4/A
CORRESP May 8, 2023
UPLOAD Apr 28, 2023
CORRESP Apr 13, 2023
← Newer Page 13 of 17 · 405 filings Older →